Last edition
News about
Lilly Positions India as Global Manufacturing Hub Amid Mounjaro Demand
Eli Lilly and Company is moving to position India as a strategic global manufacturing and export hub, supported by strong demand for its blockbuster diabetes and obesity therapy Mounjaro. A senior executive said the company is advancing plans to integrate India more deeply into its worldwide supply chain through contract manufacturing partnerships.
LEX Diagnostics wins FDA clearance for ultra-fast PCR platform to accelerate point-of-care testing
LEX Diagnostics has secured US Food and Drug Administration 510(k) clearance and CLIA waived status for its VELO molecular diagnostics system, an ultra-rapid point-of-care platform capable of delivering highly sensitive PCR results for major respiratory pathogens directly from a swab sample in under ten minutes.
<br />
Genentech's Gazyva Shows Strong Phase III Results in Primary Membranous Nephropathy
Phase III MAJESTY trial shows Gazyva significantly improves complete remission rates in primary membranous nephropathy, potentially paving the way for the first targeted therapy for the condition.
Lilly's Retevmo Shows Significant Benefit in Early-Stage RET+ Lung Cancer in Phase III Trial
LIBRETTO-432 study demonstrates statistically significant improvement in event-free survival as adjuvant therapy for stage II–IIIA RET fusion-positive NSCLC.
Bio-Techne Corporation has received CE-IVD marking for its Ella benchtop immunoassay platform, enabling commercial availability across the European Union and opening new opportunities for clinical diagnostic use.
Newron Pharmaceuticals Secures Euro 38 Million to Advance Phase III Schizophrenia Programme
Newron Pharmaceuticals strengthens its funding base with a multi-tranche equity raise to support late-stage development of evenamide in treatment-resistant schizophrenia.
Worldwide Clinical Trials Completes Acquisition of Oncology-Focused CRO Catalyst Clinical Research
Worldwide Clinical Trials strengthens its oncology and early-phase research capabilities following the completion of its acquisition of Catalyst Clinical Research.
Sanofi expands Hyderabad GCC to scale pharma manufacturing and digital operations hub
Sanofi Healthcare India Pvt. Ltd. has expanded its Global Capability Centre (GCC) in Hyderabad with the addition of more than 2.7 lakh square meters of advanced workspace within its existing campus in Hitech City.
Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada
Lupin Limited has signed a licence and supply agreement with Spektus Pharma to commercialize DeslaFlex, a novel antidepressant, in Canada.
Hikal Ltd posts quarterly loss as pharma manufacturing operations return to recovery
Hikal Ltd reported a net loss of INR 5.9 crore in the third quarter of FY26, compared with a profit of INR 17.2 crore in the corresponding quarter last year. Despite the loss, total revenue from operations increased 10.4 per cent year on year to INR 494.3 crore, up from INR 447.7 crore.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy